APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti Influenza Virus Chinese Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Anti Influenza Virus Chinese Medicine Industry Research Report 2026

2 January 2026151 pages

Choose your research edition.

Industry ResearchAnti Influenza Virus Chinese Medicine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti Influenza Virus Chinese Medicine Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Anti Influenza Virus Chinese Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti Influenza Virus Chinese Medicine Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti Influenza Virus Chinese Medicine Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Anti Influenza Virus Chinese Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Anti Influenza Virus Chinese Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Anti Influenza Virus Chinese Medicine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Anti Influenza Virus Chinese Medicine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Anti Influenza Virus Chinese Medicine include China TCM, ZBD Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Zhejiang Conba Pharmaceutical, Changbaishan Pharmaceutical, Yunnan Baiyao, Yiling Pharmaceutical, Wuzhou Pharmaceutical and Tongrentang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Anti Influenza Virus Chinese Medicine market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Anti Influenza Virus Chinese Medicine Market by Company

China TCM

ZBD Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Zhejiang Conba Pharmaceutical

Changbaishan Pharmaceutical

Yunnan Baiyao

Yiling Pharmaceutical

Wuzhou Pharmaceutical

Tongrentang

Yusheng Pharmaceutical

TASLY

Chase Sun Pharmaceutical

Green Valley Pharma

Livzon

Qingfeng Pharmaceutical Group

Jumpcan

CR SANJIU

Gerun Pharmaceutical

Fusen Pharmaceutical

Shineway Pharmaceutical

Harbin Pharmaceutical Group

Harbin Pharmaceutical Group

Guangzhou Pharmaceutical

Buchang Pharmaceutical

Anti Influenza Virus Chinese Medicine Segment by Type

Injection

Syrup

Aerosol

Oral Solution

Particles

Chewable Tablets

Capsule

Lozenges

Pills

Anti Influenza Virus Chinese Medicine Segment by Application

Adult

Children

Anti Influenza Virus Chinese Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti Influenza Virus Chinese Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti Influenza Virus Chinese Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti Influenza Virus Chinese Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Anti Influenza Virus Chinese Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Anti Influenza Virus Chinese Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Anti Influenza Virus Chinese Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti Influenza Virus Chinese Medicine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Anti Influenza Virus Chinese Medicine Sales (K Tons) of Manufacturers (2021-2026) Table 7. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Anti Influenza Virus Chinese Medicine Revenue of Manufacturers (2021-2026) Table 9. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Anti Influenza Virus Chinese Medicine Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Anti Influenza Virus Chinese Medicine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Anti Influenza Virus Chinese Medicine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Anti Influenza Virus Chinese Medicine, Product Type & Application Table 14. Global Anti Influenza Virus Chinese Medicine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Anti Influenza Virus Chinese Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. China TCM Company Information Table 19. China TCM Business Overview Table 20. China TCM Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. China TCM Anti Influenza Virus Chinese Medicine Product Portfolio Table 22. China TCM Recent Developments Table 23. ZBD Pharmaceutical Company Information Table 24. ZBD Pharmaceutical Business Overview Table 25. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 27. ZBD Pharmaceutical Recent Developments Table 28. Zhejiang Kanglaite Pharmaceutical Company Information Table 29. Zhejiang Kanglaite Pharmaceutical Business Overview Table 30. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 32. Zhejiang Kanglaite Pharmaceutical Recent Developments Table 33. Zhejiang Conba Pharmaceutical Company Information Table 34. Zhejiang Conba Pharmaceutical Business Overview Table 35. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 37. Zhejiang Conba Pharmaceutical Recent Developments Table 38. Changbaishan Pharmaceutical Company Information Table 39. Changbaishan Pharmaceutical Business Overview Table 40. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 42. Changbaishan Pharmaceutical Recent Developments Table 43. Yunnan Baiyao Company Information Table 44. Yunnan Baiyao Business Overview Table 45. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio Table 47. Yunnan Baiyao Recent Developments Table 48. Yiling Pharmaceutical Company Information Table 49. Yiling Pharmaceutical Business Overview Table 50. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 52. Yiling Pharmaceutical Recent Developments Table 53. Wuzhou Pharmaceutical Company Information Table 54. Wuzhou Pharmaceutical Business Overview Table 55. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 57. Wuzhou Pharmaceutical Recent Developments Table 58. Tongrentang Company Information Table 59. Tongrentang Business Overview Table 60. Tongrentang Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio Table 62. Tongrentang Recent Developments Table 63. Yusheng Pharmaceutical Company Information Table 64. Yusheng Pharmaceutical Business Overview Table 65. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 67. Yusheng Pharmaceutical Recent Developments Table 68. TASLY Company Information Table 69. TASLY Business Overview Table 70. TASLY Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. TASLY Anti Influenza Virus Chinese Medicine Product Portfolio Table 72. TASLY Recent Developments Table 73. Chase Sun Pharmaceutical Company Information Table 74. Chase Sun Pharmaceutical Business Overview Table 75. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 77. Chase Sun Pharmaceutical Recent Developments Table 78. Green Valley Pharma Company Information Table 79. Green Valley Pharma Business Overview Table 80. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio Table 82. Green Valley Pharma Recent Developments Table 83. Livzon Company Information Table 84. Livzon Business Overview Table 85. Livzon Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Livzon Anti Influenza Virus Chinese Medicine Product Portfolio Table 87. Livzon Recent Developments Table 88. Qingfeng Pharmaceutical Group Company Information Table 89. Qingfeng Pharmaceutical Group Business Overview Table 90. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 92. Qingfeng Pharmaceutical Group Recent Developments Table 93. Jumpcan Company Information Table 94. Jumpcan Business Overview Table 95. Jumpcan Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio Table 97. Jumpcan Recent Developments Table 98. CR SANJIU Company Information Table 99. CR SANJIU Business Overview Table 100. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio Table 102. CR SANJIU Recent Developments Table 103. Gerun Pharmaceutical Company Information Table 104. Gerun Pharmaceutical Business Overview Table 105. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 107. Gerun Pharmaceutical Recent Developments Table 108. Fusen Pharmaceutical Company Information Table 109. Fusen Pharmaceutical Business Overview Table 110. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 112. Fusen Pharmaceutical Recent Developments Table 113. Shineway Pharmaceutical Company Information Table 114. Shineway Pharmaceutical Business Overview Table 115. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 117. Shineway Pharmaceutical Recent Developments Table 118. Harbin Pharmaceutical Group Company Information Table 119. Harbin Pharmaceutical Group Business Overview Table 120. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 122. Harbin Pharmaceutical Group Recent Developments Table 123. Harbin Pharmaceutical Group Company Information Table 124. Harbin Pharmaceutical Group Business Overview Table 125. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 127. Harbin Pharmaceutical Group Recent Developments Table 128. Guangzhou Pharmaceutical Company Information Table 129. Guangzhou Pharmaceutical Business Overview Table 130. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 132. Guangzhou Pharmaceutical Recent Developments Table 133. Buchang Pharmaceutical Company Information Table 134. Buchang Pharmaceutical Business Overview Table 135. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 137. Buchang Pharmaceutical Recent Developments Table 138. Global Anti Influenza Virus Chinese Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (K Tons) Table 140. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2021-2026) Table 141. Global Anti Influenza Virus Chinese Medicine Sales by Region (2027-2032) & (K Tons) Table 142. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2027-2032) Table 143. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2021-2026) Table 145. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2027-2032) Table 147. North America Anti Influenza Virus Chinese Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 149. North America Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 150. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Anti Influenza Virus Chinese Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 154. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 155. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 159. Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 160. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Anti Influenza Virus Chinese Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 164. South America Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 165. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 169. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2027-2032) & (K Tons) Table 170. Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 173. Global Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 174. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2026) Table 175. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2027-2032) Table 176. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2026) Table 179. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2027-2032) Table 180. Global Anti Influenza Virus Chinese Medicine Price by Type (2021-2026) & (US$/Ton) Table 181. Global Anti Influenza Virus Chinese Medicine Price by Type (2027-2032) & (US$/Ton) Table 182. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 183. Global Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 184. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2026) Table 185. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2027-2032) Table 186. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2026) Table 189. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2027-2032) Table 190. Global Anti Influenza Virus Chinese Medicine Price by Application (2021-2026) & (US$/Ton) Table 191. Global Anti Influenza Virus Chinese Medicine Price by Application (2027-2032) & (US$/Ton) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Anti Influenza Virus Chinese Medicine Distributors List Table 195. Anti Influenza Virus Chinese Medicine Customers List Table 196. Anti Influenza Virus Chinese Medicine Industry Trends Table 197. Anti Influenza Virus Chinese Medicine Industry Drivers Table 198. Anti Influenza Virus Chinese Medicine Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Anti Influenza Virus Chinese Medicine Product Image Figure 5. Global Anti Influenza Virus Chinese Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Anti Influenza Virus Chinese Medicine Market Size (2021-2032) & (US$ Million) Figure 7. Global Anti Influenza Virus Chinese Medicine Sales (2021-2032) & (K Tons) Figure 8. Global Anti Influenza Virus Chinese Medicine Average Price (US$/Ton) & (2021-2032) Figure 9. Injection Product Image Figure 10. Syrup Product Image Figure 11. Aerosol Product Image Figure 12. Oral Solution Product Image Figure 13. Particles Product Image Figure 14. Chewable Tablets Product Image Figure 15. Capsule Product Image Figure 16. Lozenges Product Image Figure 17. Pills Product Image Figure 18. Adult Product Image Figure 19. Children Product Image Figure 20. Global Anti Influenza Virus Chinese Medicine Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Anti Influenza Virus Chinese Medicine, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Anti Influenza Virus Chinese Medicine Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Anti Influenza Virus Chinese Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Anti Influenza Virus Chinese Medicine Sales by Region in 2025 Figure 26. Global Anti Influenza Virus Chinese Medicine Revenue by Region in 2025 Figure 27. North America Anti Influenza Virus Chinese Medicine Market Size by Country in 2025 Figure 28. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2032) Figure 29. North America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2021-2032) Figure 30. United States Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Anti Influenza Virus Chinese Medicine Market Size by Country in 2025 Figure 33. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2032) Figure 34. Europe Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2021-2032) Figure 35. Germany Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Anti Influenza Virus Chinese Medicine Market Size by Country in 2025 Figure 41. Asia Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2021-2032) Figure 43. China Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. China Taiwan Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Anti Influenza Virus Chinese Medicine Market Size by Country in 2025 Figure 52. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2032) Figure 53. South America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2021-2032) Figure 54. Mexico Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Brazil Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country in 2025 Figure 58. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2021-2032) Figure 60. Turkey Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. UAE Anti Influenza Virus Chinese Medicine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2032) Figure 64. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2032) Figure 65. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Type (2021-2032) Figure 66. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2032) Figure 67. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2032) Figure 68. Global Anti Influenza Virus Chinese Medicine Price (US$/Ton) by Application (2021-2032) Figure 69. Anti Influenza Virus Chinese Medicine Value Chain Figure 70. Anti Influenza Virus Chinese Medicine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection
  • Syrup
  • Aerosol
  • Oral Solution
  • Particles
  • Chewable Tablets
  • Capsule
  • Lozenges
  • Pills
Applications
  • Adult
  • Children
Companies covered
  • China TCM
  • ZBD Pharmaceutical
  • Zhejiang Kanglaite Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • Changbaishan Pharmaceutical
  • Yunnan Baiyao
  • Yiling Pharmaceutical
  • Wuzhou Pharmaceutical
  • Tongrentang
  • Yusheng Pharmaceutical
  • TASLY
  • Chase Sun Pharmaceutical
  • Green Valley Pharma
  • Livzon
  • Qingfeng Pharmaceutical Group
  • Jumpcan
  • CR SANJIU
  • Gerun Pharmaceutical
  • Fusen Pharmaceutical
  • Shineway Pharmaceutical
  • Harbin Pharmaceutical Group
  • Harbin Pharmaceutical Group
  • Guangzhou Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Anti Influenza Virus Chinese Medicine Market Size (2021-2032)
  4. 2.2.2 Global Anti Influenza Virus Chinese Medicine Sales (2021-2032)
  5. 2.2.3 Global Anti Influenza Virus Chinese Medicine Market Average Price (2021-2032)
  6. 2.3 Anti Influenza Virus Chinese Medicine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection
  9. 2.3.3 Syrup
  10. 2.3.4 Aerosol
  11. 2.3.5 Oral Solution
  12. 2.3.6 Particles
  13. 2.3.7 Chewable Tablets
  14. 2.3.8 Capsule
  15. 2.3.9 Lozenges
  16. 2.3.10 Pills
  17. 2.4 Anti Influenza Virus Chinese Medicine by Application
  18. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  19. 2.4.2 Adult
  20. 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Anti Influenza Virus Chinese Medicine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Anti Influenza Virus Chinese Medicine Sales (K Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Anti Influenza Virus Chinese Medicine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Anti Influenza Virus Chinese Medicine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Anti Influenza Virus Chinese Medicine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Anti Influenza Virus Chinese Medicine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Anti Influenza Virus Chinese Medicine, Product Type & Application
  8. 3.8 Global Manufacturers of Anti Influenza Virus Chinese Medicine, Established Date
  9. 3.9 Global Anti Influenza Virus Chinese Medicine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 China TCM
  2. 4.1.1 China TCM Company Information
  3. 4.1.2 China TCM Business Overview
  4. 4.1.3 China TCM Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 China TCM Anti Influenza Virus Chinese Medicine Product Portfolio
  6. 4.1.5 China TCM Recent Developments
  7. 4.2 ZBD Pharmaceutical
  8. 4.2.1 ZBD Pharmaceutical Company Information
  9. 4.2.2 ZBD Pharmaceutical Business Overview
  10. 4.2.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  12. 4.2.5 ZBD Pharmaceutical Recent Developments
  13. 4.3 Zhejiang Kanglaite Pharmaceutical
  14. 4.3.1 Zhejiang Kanglaite Pharmaceutical Company Information
  15. 4.3.2 Zhejiang Kanglaite Pharmaceutical Business Overview
  16. 4.3.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  18. 4.3.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
  19. 4.4 Zhejiang Conba Pharmaceutical
  20. 4.4.1 Zhejiang Conba Pharmaceutical Company Information
  21. 4.4.2 Zhejiang Conba Pharmaceutical Business Overview
  22. 4.4.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  24. 4.4.5 Zhejiang Conba Pharmaceutical Recent Developments
  25. 4.5 Changbaishan Pharmaceutical
  26. 4.5.1 Changbaishan Pharmaceutical Company Information
  27. 4.5.2 Changbaishan Pharmaceutical Business Overview
  28. 4.5.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  30. 4.5.5 Changbaishan Pharmaceutical Recent Developments
  31. 4.6 Yunnan Baiyao
  32. 4.6.1 Yunnan Baiyao Company Information
  33. 4.6.2 Yunnan Baiyao Business Overview
  34. 4.6.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio
  36. 4.6.5 Yunnan Baiyao Recent Developments
  37. 4.7 Yiling Pharmaceutical
  38. 4.7.1 Yiling Pharmaceutical Company Information
  39. 4.7.2 Yiling Pharmaceutical Business Overview
  40. 4.7.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  42. 4.7.5 Yiling Pharmaceutical Recent Developments
  43. 4.8 Wuzhou Pharmaceutical
  44. 4.8.1 Wuzhou Pharmaceutical Company Information
  45. 4.8.2 Wuzhou Pharmaceutical Business Overview
  46. 4.8.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  48. 4.8.5 Wuzhou Pharmaceutical Recent Developments
  49. 4.9 Tongrentang
  50. 4.9.1 Tongrentang Company Information
  51. 4.9.2 Tongrentang Business Overview
  52. 4.9.3 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio
  54. 4.9.5 Tongrentang Recent Developments
  55. 4.10 Yusheng Pharmaceutical
  56. 4.10.1 Yusheng Pharmaceutical Company Information
  57. 4.10.2 Yusheng Pharmaceutical Business Overview
  58. 4.10.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  60. 4.10.5 Yusheng Pharmaceutical Recent Developments
  61. 4.11 TASLY
  62. 4.11.1 TASLY Company Information
  63. 4.11.2 TASLY Business Overview
  64. 4.11.3 TASLY Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 TASLY Anti Influenza Virus Chinese Medicine Product Portfolio
  66. 4.11.5 TASLY Recent Developments
  67. 4.12 Chase Sun Pharmaceutical
  68. 4.12.1 Chase Sun Pharmaceutical Company Information
  69. 4.12.2 Chase Sun Pharmaceutical Business Overview
  70. 4.12.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  72. 4.12.5 Chase Sun Pharmaceutical Recent Developments
  73. 4.13 Green Valley Pharma
  74. 4.13.1 Green Valley Pharma Company Information
  75. 4.13.2 Green Valley Pharma Business Overview
  76. 4.13.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio
  78. 4.13.5 Green Valley Pharma Recent Developments
  79. 4.14 Livzon
  80. 4.14.1 Livzon Company Information
  81. 4.14.2 Livzon Business Overview
  82. 4.14.3 Livzon Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Livzon Anti Influenza Virus Chinese Medicine Product Portfolio
  84. 4.14.5 Livzon Recent Developments
  85. 4.15 Qingfeng Pharmaceutical Group
  86. 4.15.1 Qingfeng Pharmaceutical Group Company Information
  87. 4.15.2 Qingfeng Pharmaceutical Group Business Overview
  88. 4.15.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  90. 4.15.5 Qingfeng Pharmaceutical Group Recent Developments
  91. 4.16 Jumpcan
  92. 4.16.1 Jumpcan Company Information
  93. 4.16.2 Jumpcan Business Overview
  94. 4.16.3 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio
  96. 4.16.5 Jumpcan Recent Developments
  97. 4.17 CR SANJIU
  98. 4.17.1 CR SANJIU Company Information
  99. 4.17.2 CR SANJIU Business Overview
  100. 4.17.3 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio
  102. 4.17.5 CR SANJIU Recent Developments
  103. 4.18 Gerun Pharmaceutical
  104. 4.18.1 Gerun Pharmaceutical Company Information
  105. 4.18.2 Gerun Pharmaceutical Business Overview
  106. 4.18.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  108. 4.18.5 Gerun Pharmaceutical Recent Developments
  109. 4.19 Fusen Pharmaceutical
  110. 4.19.1 Fusen Pharmaceutical Company Information
  111. 4.19.2 Fusen Pharmaceutical Business Overview
  112. 4.19.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  114. 4.19.5 Fusen Pharmaceutical Recent Developments
  115. 4.20 Shineway Pharmaceutical
  116. 4.20.1 Shineway Pharmaceutical Company Information
  117. 4.20.2 Shineway Pharmaceutical Business Overview
  118. 4.20.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  120. 4.20.5 Shineway Pharmaceutical Recent Developments
  121. 4.21 Harbin Pharmaceutical Group
  122. 4.21.1 Harbin Pharmaceutical Group Company Information
  123. 4.21.2 Harbin Pharmaceutical Group Business Overview
  124. 4.21.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  126. 4.21.5 Harbin Pharmaceutical Group Recent Developments
  127. 4.22 Harbin Pharmaceutical Group
  128. 4.22.1 Harbin Pharmaceutical Group Company Information
  129. 4.22.2 Harbin Pharmaceutical Group Business Overview
  130. 4.22.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  132. 4.22.5 Harbin Pharmaceutical Group Recent Developments
  133. 4.23 Guangzhou Pharmaceutical
  134. 4.23.1 Guangzhou Pharmaceutical Company Information
  135. 4.23.2 Guangzhou Pharmaceutical Business Overview
  136. 4.23.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  138. 4.23.5 Guangzhou Pharmaceutical Recent Developments
  139. 4.24 Buchang Pharmaceutical
  140. 4.24.1 Buchang Pharmaceutical Company Information
  141. 4.24.2 Buchang Pharmaceutical Business Overview
  142. 4.24.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  144. 4.24.5 Buchang Pharmaceutical Recent Developments
5 Global Anti Influenza Virus Chinese Medicine Market Scenario by Region
  1. 5.1 Global Anti Influenza Virus Chinese Medicine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2021-2032
  3. 5.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2021-2026
  4. 5.2.2 Global Anti Influenza Virus Chinese Medicine Sales by Region: 2027-2032
  5. 5.3 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2021-2032
  6. 5.3.1 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2021-2026
  7. 5.3.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region: 2027-2032
  8. 5.4 North America Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
  9. 5.4.1 North America Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2032)
  11. 5.4.3 North America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
  15. 5.5.1 Europe Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2032)
  17. 5.5.3 Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
  35. 5.7.1 South America Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2032)
  37. 5.7.3 South America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032)
  2. 6.1.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032) & (K Tons)
  3. 6.1.2 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2032)
  5. 6.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Anti Influenza Virus Chinese Medicine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032)
  2. 7.1.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032) & (K Tons)
  3. 7.1.2 Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2032)
  5. 7.2.1 Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Anti Influenza Virus Chinese Medicine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Anti Influenza Virus Chinese Medicine Value Chain Analysis
  2. 8.1.1 Anti Influenza Virus Chinese Medicine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Anti Influenza Virus Chinese Medicine Production Mode & Process
  5. 8.2 Anti Influenza Virus Chinese Medicine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Anti Influenza Virus Chinese Medicine Distributors
  8. 8.2.3 Anti Influenza Virus Chinese Medicine Customers
9 Global Anti Influenza Virus Chinese Medicine Analyzing Market Dynamics
  1. 9.1 Anti Influenza Virus Chinese Medicine Industry Trends
  2. 9.2 Anti Influenza Virus Chinese Medicine Industry Drivers
  3. 9.3 Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges
  4. 9.4 Anti Influenza Virus Chinese Medicine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst